67 biotech companies
Thematic research funding
The goal of the Genopole® Research Group Establishment Grants (ATIGE grants) is to offer to promising young staff researchers - tomorrow’s scientific leaders - the possibility of establishing and developing their own research group within a government research institute or a university lab located on the Evry-Corbeil biopark.
ATIGE grants are awarded for up to 3 years to researchers holding a permanent position in a government research institute or likely to obtain one before award of the grant.
The research project must fall within Genopole®’s strategic fields of interest:
genomics, postgenomics, biotherapies, bioinformatics, biophysics and the engineering sciences applied to large-scale biology (transcriptomics, proteomics, metabolomics, systemic biology, synthetic biology, etc.). _
ATIGE grant holders are selected by an independent scientific committee after an annual call for applications launched by Genopole®.
After project review and selection, funding of €76,500 per year (including costs and admin charges) is awarded, with the possibility of recruiting technical assistants on temporary contracts.
Since 2001, Genopole® has awarded sixteen 3-year ATIGE grants (including one financed by the AFM). As of late 2007, five were still running. For the eleven completed grants, seven of the grant holders have stayed on in their host lab, one has created a new INSERM/UEVE research unit and three have left the biopark.
ATIGE grants are awarded for up to 3 years to researchers holding a permanent position in a government research institute or likely to obtain one before award of the grant.
The research project must fall within Genopole®’s strategic fields of interest:
genomics, postgenomics, biotherapies, bioinformatics, biophysics and the engineering sciences applied to large-scale biology (transcriptomics, proteomics, metabolomics, systemic biology, synthetic biology, etc.). _
ATIGE grant holders are selected by an independent scientific committee after an annual call for applications launched by Genopole®.
After project review and selection, funding of €76,500 per year (including costs and admin charges) is awarded, with the possibility of recruiting technical assistants on temporary contracts.
Since 2001, Genopole® has awarded sixteen 3-year ATIGE grants (including one financed by the AFM). As of late 2007, five were still running. For the eleven completed grants, seven of the grant holders have stayed on in their host lab, one has created a new INSERM/UEVE research unit and three have left the biopark.
Latest News
NYSE Euronext welcomes Novagali on its (...)
Novagali Pharma, a pharmaceutical company (...)
Biosystems 
International raises 
2,1
M€
Biosystems
 International
 (BSI) SAS,
 biotech (...)
Collaboration between Cancer Campus & (...)
Genopole® (Evry) & Cancer Campus® (Villejuif)
Introduction en bourse de Novagali sur NYSE (...)
A la suite de l’enregistrement par l’Autorité (...)
